# Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

> **NCT06336902** · PHASE1 · RECRUITING · sponsor: **University of Southern California** · enrollment: 15 (estimated)

## Conditions studied

- Metastatic Colorectal Adenocarcinoma
- Stage IV Colorectal Cancer AJCC v8

## Interventions

- **BIOLOGICAL:** Balstilimab
- **PROCEDURE:** Biospecimen Collection
- **BIOLOGICAL:** Botensilimab
- **PROCEDURE:** Computed Tomography
- **OTHER:** Dietary Intervention
- **PROCEDURE:** Magnetic Resonance Imaging
- **DIETARY_SUPPLEMENT:** Vitamin C

## Key facts

- **NCT ID:** NCT06336902
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2027-01-15
- **Final completion:** 2028-01-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06336902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06336902, "Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06336902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*